Loracarbef
At a glance
- Drug Originator Kyowa Hakko
- Drug Licenced by Eli Lilly and Company; Pfizer
- Drug Class Antibacterials; Cephalosporins; Small molecules
- Mechanism of Action Cell wall inhibitors
- USA Patent Applicants KING PHARMS
- NDAs 2
- Patent Applications 5,076
Table of Contents
Disclaimer